Form 4: Gossamer Bio Executive Robert Paul Smith JR Acquires 25,000 Shares
SEC Form 4 Filing
Robert Paul Smith JR, Chief Commercial Officer of Gossamer Bio, Inc., acquired 25,000 shares of common stock at $0.602 per share on June 17, 2024.
Summary
- On June 17, 2024, Robert Paul Smith JR, the Chief Commercial Officer of Gossamer Bio, Inc., purchased 25,000 shares of the company's common stock.
- The shares were acquired at a price of $0.602 per share.
- Following the transaction, Smith beneficially owns 25,000 shares indirectly through a family trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. An insider buying shares is generally a good sign, but the quantity is not large enough to be a major market mover.
Positives
- An executive's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into a company's performance and future expectations. This purchase by a key executive may influence investor sentiment towards Gossamer Bio.
Stakeholder Impact
- The purchase could positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of the transaction where Robert Paul Smith JR acquired 25,000 shares of Gossamer Bio, Inc. |
| 06/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.